SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000895345-24-000025
Filing Date
2024-02-05
Accepted
2024-02-05 13:20:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 ff2963798_13ga3-kapnick.htm SC 13G/A 54984
  Complete submission text file 0000895345-24-000025.txt   56344
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90032 | Film No.: 24594978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Kapnick Scott (Filed by) CIK: 0001709654 (see all company filings)

Type: SC 13G/A